The Liver Disease Virtual Roundtable is an educational series for health care professionals. It began in 2016, and it is headed by Andrew Aronsohn, MD, Director of Telehealth for the University of Chicago Medicine Digestive Diseases.

This program is dedicated to sharing information about liver disease — including viral hepatitis, nonalcoholic steatohepatitis (NASH), complications of cirrhosis, liver transplantation and liver tumors — with colleagues and physicians in the field. UChicago Medicine's Center for Liver Diseases and Transplant Institute applies the latest research to care for medically complex patients with new surgical techniques, opportunities for expanded indications for liver transplant as well as medical therapy with clinical trials.

The Liver Case Roundtable program brings this knowledge to physicians around the world who can use this monthly session to share their own patient care questions and experiences. Physicians can consult with our UChicago Medicine liver team to determine the best course for their patients’ wellness. We welcome presentations from community-based practices as well as academic centers as points of discussion not only to offer recommendations in care for individual patients, but also, to create an effective learning environment for all participants.

Who can attend these sessions?

These sessions are open to any interested physicians, nurses, student, residents, fellows or allied health professionals interested in learning more about these topics. Our sessions cannot accommodate patient participants at this time.

Liver Case Virtual Roundtable Schedule
4:30 - 5:30 p.m. CST 

September 19, 2023 — “The Journey From Tumor Immunology to Transplant Immunology to Transplant Oncology Comes Full Circle”
with John Fung, MD, PhD

October 17, 2023 — “Update in Autoimmune Hepatitis”
with Andrew Aronsohn, MD

November 21, 2023 — “From NAFLD to MASLD: How to identify and patients at risk for adverse outcomes”
with Mary Rinella, MD

December 19, 2023 — Cancelled 

January 16, 2024 —

“Updates in Portal Hypertension” 
with Matthew Odenwald, MD, PhD

“The Challenges of a Normal Liver Biopsy”
with Claus Fimmel, MD

February 20, 2024 — “Applauding Alcohol Cessation: A Review on AUD Therapies”
with Anesia Reticker, PharmD

March 19, 2024 — “TIPS or LDLT in Patients with low MELD and Complications of Portal Hypertension – A case-based approach”
with Michael Charlton, MD

April 16, 2024 — “A New Facet of Cryptogenic Cirrhosis (and more…)”
with Helen Te, MD

June 18, 2024 — “The Development of Tacrolimus”
with John Fung, MD

Frequently Asked Questions

When are the meetings held?

Third Tuesday of the month

Are the sessions recorded?

At this time, we do not offer a recorded version of these conferences

How do you protect patient privacy?

No identifying information about patients is shared during these sessions, in compliance with HIPAA laws.

How do I get CME credit?

You must first register to attend the conference, and then the telehealth conference coordinator will assist in setting up your account so you can access CME credit for attending these sessions.

Who can I contact to learn more?

Center for Liver Diseases

We offer leading-edge approaches for diagnosing and treating the full range of chronic and acute liver diseases in adults. In addition to receiving the most effective therapies, patients here receive personalized support and patient education to help them cope with long-term illness and treatment.

Learn more about our liver health services